[Value of mazindol in Gélineau's disease. Apropos of 10 cases]

Rev Electroencephalogr Neurophysiol Clin. 1986 Oct;16(3):317-22. doi: 10.1016/s0370-4475(86)80059-4.
[Article in French]

Abstract

Ten narcoleptic patients were treated daily with Mazindol 2-6 mg for 42.2 months (31-63 months). The response was excellent on narcoleptic attacks in 6 and on cataplexy in 7 cases. However, the nocturnal sleep disturbance persisted unchanged. The improvement was poor in 1 case and inexistant in 1 subject. Minor side effects (dry mouth) occurred in 3 cases, and urinary retention obliged to stop the medication in 2 cases.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Catalepsy / drug therapy
  • Clomipramine / administration & dosage
  • Drug Therapy, Combination
  • Female
  • Humans
  • Indoles / therapeutic use*
  • Male
  • Mazindol / administration & dosage
  • Mazindol / adverse effects
  • Mazindol / therapeutic use*
  • Middle Aged
  • Narcolepsy / drug therapy*
  • Urination Disorders / chemically induced
  • Xerostomia / chemically induced

Substances

  • Indoles
  • Mazindol
  • Clomipramine